Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GALECTIN THERAPEUTICS INC | Director, 10%+ Owner | Common Stock | 10.3M | $17.7M | $1.72 | Jan 24, 2024 | Direct |
GALECTIN THERAPEUTICS INC | Director, 10%+ Owner | Common Stock | 27.7K | $47.7K | $1.72 | Jan 24, 2024 | By Ed Uihlein Family Foundation |
GALECTIN THERAPEUTICS INC | Director, 10%+ Owner | Stock Option (right to buy) | 50K | Jan 24, 2024 | Direct | ||
GALECTIN THERAPEUTICS INC | Director, 10%+ Owner | Common Stock Purchase Warrant (right to buy) | 0 | Sep 26, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GALT | GALECTIN THERAPEUTICS INC | Jan 24, 2024 | 2 | $40K | 4 | Feb 7, 2024 | Director, 10%+ Owner |
GALT | GALECTIN THERAPEUTICS INC | Sep 26, 2023 | 10 | $10M | 4 | Sep 27, 2023 | Director, 10%+ Owner |
GALT | GALECTIN THERAPEUTICS INC | Jan 26, 2023 | 2 | $40K | 4 | Jan 30, 2023 | Director, 10%+ Owner |
GALT | GALECTIN THERAPEUTICS INC | Jan 24, 2022 | 2 | $35K | 4 | Feb 8, 2022 | Director, 10%+ Owner |
GALT | GALECTIN THERAPEUTICS INC | Dec 20, 2021 | 1 | $18.4T | 4 | Jan 25, 2022 | Director, 10%+ Owner |
GALT | GALECTIN THERAPEUTICS INC | Sep 17, 2021 | 1 | $11.6T | 4 | Sep 21, 2021 | Director, 10%+ Owner |